AHA 2016: An Update of Emerging Therapeutics to Prevent Stroke in Patients with Non-Valvular Atrial Fibrillation

http://academiccme.com/wp-content/uploads/2017/01/910677-125-x-125.jpg

Course Information

Therapautic Area: Cardiology
Format(s): Meeting Reporter, Downloadable PDF
Credit(s): 1.00 AMA PRA Category 1 Credit(s)™
Activity Dates: February 9, 2016 to February 8, 2017

 

Program Overview

This Official Elsevier Meeting Reporter will highlight recent science and clinical strategies for the management of patients with atrial fibrillation presented at the American Heart Association Scientific Sessions 2016 held in New Orleans, Louisiana. Expert faculty will discuss anticoagulant management, including prevention, diagnostic criteria and current treatment options.  Updates on existing tactics for preventing stroke in patients with atrial fibrillation will also be covered in the duration of this discussion-based activity. Faculty will relay optimal methods for educating newly diagnosed individuals and improving patient-physician communication lines as treatment progresses. Upon completion of this program, learners will find themselves better acquainted with the current science needed for accurate diagnosis as well as quality of life improvement in patients with atrial fibrillation.

Target Audience

This activity has been designed to meet the educational needs of health care professionals involved in the diagnosis, treatment, or management of patients with atrial fibrillation.

Educational Objectives

  1. Discuss atrial fibrillation science, including diagnostic criteria, prevention and treatment options.
  2. Analyze clinical trial data for emerging reversal therapeutics for stroke prevention in patients with atrial fibrillation as presented at AHA 2016.
  3. Integrate patient education and communication strategies into individualized treatment plans to reduce the risk of stroke in patients with non-valvular atrial fibrillation.

Faculty

Pollack_Headshot #119 AHA AFibCharles V. Pollack, MD
Associate Provost for Innovation in Education, Thomas Jefferson University
Director, Jefferson Institute of Emerging Health Professions
Sidney Kimmel Medical College of Thomas Jefferson University
Philadelphia, Pennsylvania

 

 

Ezekowitz_Headshot #119 AHA AfibMichael D. Ezekowitz, MD, PhD
Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Department of Cardiovascular Medicine
Lankenau and Bryn Mawr Medical Centers
Philadelphia, Pennsylvania

 

Ruff_Headshot #119 AHA AfibChristian T. Ruff, MD, MPH
TIMI Study Group
Brigham and Women’s Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

 


Registration



This CME activity has been supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Co-provided by the Elsevier Office of Continuing Medical Education and AcademicCME.

eocme acme logo